Personalized Lifestyle Program in Treatment Resistant Irritable Bowel Syndrome
Primary Purpose
Irritable Bowel Syndrome
Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Personalized lifestyle treatment program
Sponsored by
About this trial
This is an interventional treatment trial for Irritable Bowel Syndrome
Eligibility Criteria
Inclusion Criteria:
- Fulfills Rome IV criteria for IBS
- Symptom burden on IBS-SSS >175
- No symptom relief from standard medical treatment
- No organic finding explaining the IBS symptoms (e.g. inflammation, parasites, thyroid disease, lactose intolerance, celiac disease, bile acid malabsorption)
Exclusion Criteria:
- Pregnancy
- Disease or life circumstances that prevent participation in the treatment program
Sites / Locations
- Karolinska Institutet Departmend of Medicine HuddingRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Personalized lifestyle intervention
Arm Description
The intervention consists of a personalized lifestyle treatment program to address specific lifestyle issues.
Outcomes
Primary Outcome Measures
Proportion recovery from diagnosis of IBS
Rome IV questionnaire is used to establish whether the participant fulfills the criteria for IBS at 12 months follow up
Secondary Outcome Measures
Change in BS severity symptom scale score
Assessed using the IBS severity symptom scale (IBS-SSS) which goes from 0-500. At least 150 is required to enter the study. A change of 75 is usually considered clinically relevant
Change in total symptom burden
Assessed using Gastrointestinal symptom rating scale for IBS (GSRS-IBS) scores This scale has 13 items, each scored 1-7 so the score goes from 13-91
Change in work ability
The participant is asked to rate its work ability and to report current employment rate and sick leave.
Full Information
NCT ID
NCT05028036
First Posted
August 24, 2021
Last Updated
June 19, 2023
Sponsor
Karolinska Institutet
Collaborators
Stockholm University, Karolinska University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05028036
Brief Title
Personalized Lifestyle Program in Treatment Resistant Irritable Bowel Syndrome
Official Title
Personalized Lifestyle Program in Treatment Resistant Irritable Bowel Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 14, 2021 (Actual)
Primary Completion Date
September 14, 2024 (Anticipated)
Study Completion Date
September 14, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
Collaborators
Stockholm University, Karolinska University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Patients with treatment resistant irritable bowel syndrome (IBS) are recruited from secondary care gastroenterology clinics in Stockholm and screened for eligibility criteria. Participants follow a 12 month treatment program at Nordic Clinic, a clinic offering personalized lifestyle interventions based on the functional medicine model. In parallel with the treatment program, the participant are clinically assessed for the evaluation of the treatment after 6 months, 12 months, 18 months and 24 months
Detailed Description
Patients with treatment resistant irritable bowel syndrome (IBS) are recruited from secondary care gastroenterology clinics in Stockholm. Eligible participants are screened for eligibility criteria at a baseline visit at the Karolinska Institutet. Patients providing written informed consent for participation are invited to Nordic Clinic, a clinic offering personalized lifestyle interventions based on the functional medicine model. Before the first visit to the clinic, the participant fill out a longer questionnaire that is used for the planning of the participant's personal treatment program. At the first visit, the therapist goes through the responses together with the participant. Based on the participant's symptom profile, it is determined which tests are taken in the first step. Based on symptoms and test results, the therapist and participant come up with a treatment plan that can include several of the following components:
Dietary changes
Dietary supplements
Measures to improve sleep / circadian rhythm
Stress management
Physical exercise
Medicines, in exceptional cases.
The treatment plan is evaluated continuously by the participant and the therapist and adjusted accordingly.
The treatment involves a total of 9 visits to the Nordic Clinic during one year. The subsequent visits are planned by the therapist at the Nordic Clinic together with the participant.
In parallel with the treatment program, the participant makes return visits to Karolinska Institutet to collect follow-up data for the evaluation of the treatment after 6 months, 12 months, 18 months and 24 months after the start of treatment where participants are clinically assessed and fill out forms for the evaluation of treatment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Irritable Bowel Syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Personalized lifestyle intervention
Arm Type
Experimental
Arm Description
The intervention consists of a personalized lifestyle treatment program to address specific lifestyle issues.
Intervention Type
Other
Intervention Name(s)
Personalized lifestyle treatment program
Intervention Description
The personalized treatment program is based on the participants symptom profile and test results and is designed in collaboration with the participant. The treatment plan that may include several of the following components:
Dietary changes
Supplements
Measures to improve sleep / circadian rhythm
Stress management
Physical exercise
The treatment plan is evaluated continuously by the participant and the therapist and adjusted accordingly. A total of 9 visits to the Nordic Clinic over one year is included in the treatment program.
Primary Outcome Measure Information:
Title
Proportion recovery from diagnosis of IBS
Description
Rome IV questionnaire is used to establish whether the participant fulfills the criteria for IBS at 12 months follow up
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Change in BS severity symptom scale score
Description
Assessed using the IBS severity symptom scale (IBS-SSS) which goes from 0-500. At least 150 is required to enter the study. A change of 75 is usually considered clinically relevant
Time Frame
Baseline, 6, 12, 18 and 24 months
Title
Change in total symptom burden
Description
Assessed using Gastrointestinal symptom rating scale for IBS (GSRS-IBS) scores This scale has 13 items, each scored 1-7 so the score goes from 13-91
Time Frame
Baseline, 6, 12, 18 and 24 months
Title
Change in work ability
Description
The participant is asked to rate its work ability and to report current employment rate and sick leave.
Time Frame
Baseline, 6, 12, 18 and 24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Fulfills Rome IV criteria for IBS
Symptom burden on IBS-SSS >175
No symptom relief from standard medical treatment
No organic finding explaining the IBS symptoms (e.g. inflammation, parasites, thyroid disease, lactose intolerance, celiac disease, bile acid malabsorption)
Exclusion Criteria:
Pregnancy
Disease or life circumstances that prevent participation in the treatment program
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Greger Lindberg
Phone
+46736997395
Email
greger.lindberg@ki.se
First Name & Middle Initial & Last Name or Official Title & Degree
Anna Andreasson
Email
anna.andreasson@ki.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Greger Lindberg
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karolinska Institutet Departmend of Medicine Hudding
City
Huddinge
State/Province
Stockholm
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Greger Lindberg
Email
greger.lindberg@ki.se
First Name & Middle Initial & Last Name & Degree
Greger Lindberg
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Personalized Lifestyle Program in Treatment Resistant Irritable Bowel Syndrome
We'll reach out to this number within 24 hrs